The article presents the detailed key provisions of the clinical recommendations on providing medical care to children with Kawasaki syndrome/illness, developed by the professional association of pediatric specialists — the Union of Pediatricians of Russia. The current data on the prevalence of pathology is presented, the characteristic diagnostic signs of the disease are given that allow to make a diagnosis as soon as possible and immediately appoint a specific treatment. Therapeutic measures carried out in the required volume determine the further prognosis. The comprehensive approach to the management of pediatric patients with this nosology presented in the article will ensure a high level of medical care quality provided to children with Kawasaki syndrome.

The etiology of respiratory diseases (RD) is represented by viral and bacterial pathogens [1]. Obviously, viral infections cause most of respiratory diseases in children, while antibiotic treatment is at least useless and often considered inefficient due to a multitude of adverse events. Antibiotics may cause allergic reactions, impair biocenosis of the respiratory tract and colonization of its mucous membranes with unwanted, often intestinal, flora. The greatest danger, however, is the development of overall antibiotic resistance of microbial flora which currently is one of the most serious public healthcare problems [2]. At the same time, bacterial infection, in case of late detection and inadequate treatment, poses a greater risk for serious complications and therefore requires reasonable prescription of systemic antibiotic therapy.